It is unclear what proportion of dementia is due to vascular risk factors. There is some evidence from European studies that a decrease in the incidence of dementia corresponds with improved cardiovascular health.[10]Perneczky R, Tene O, Attems J, et al. Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group. BMC Med. 2016 Nov 3;14(1):162.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093932
http://www.ncbi.nlm.nih.gov/pubmed/27806707?tool=bestpractice.com
[47]Peters R, Xu Y, Fitzgerald O, et al. Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. Eur Heart J. 2022 Dec 21;43(48):4980-90.
https://academic.oup.com/eurheartj/article/43/48/4980/6770632
http://www.ncbi.nlm.nih.gov/pubmed/36282295?tool=bestpractice.com
High-risk groups - that is, older patients with hypertension, diabetes, obesity, atrial fibrillation, past transient ischemic attack (TIA), or stroke, or who drink to excess or smoke - should be targeted for primary prevention in the following ways:
Optimal treatment of hypertension and diabetes
Reduction in BMI through dietary changes and graduated low-impact physical activity/exercise
Antiplatelet therapy for patients with history of TIA, stroke, or coronary disease
Encouraging patients to stop smoking and decrease alcohol consumption
Control of hyperlipidemia
Rhythm control strategies (particularly ablation) and anticoagulation treatment for patients with atrial fibrillation[48]Guo J, Liu Y, Jia J, et al. Effects of rhythm-control and rate-control strategies on cognitive function and dementia in atrial fibrillation: a systematic review and meta-analysis. Age Ageing. 2024 Feb 1;53(2):afae009.
http://www.ncbi.nlm.nih.gov/pubmed/38369630?tool=bestpractice.com
Treatment of high-grade carotid stenosis with antiplatelet agents or carotid endarterectomy
One cohort study concluded that potentially modifiable midlife vascular risk factors are associated with increased risk of dementia in later life, and that further studies are needed to assess the effects of risk factor control.[49]Gottesman RF, Albert MS, Alonso A, et al. Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort. JAMA Neurol. 2017 Oct 1;74(10):1246-54.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710244
http://www.ncbi.nlm.nih.gov/pubmed/28783817?tool=bestpractice.com
In another study, higher cardiovascular risk burden was associated with some aspects of cognitive decline and structural brain changes.[50]Song R, Xu H, Dintica CS, et al. Associations between cardiovascular risk, structural brain changes, and cognitive decline. J Am Coll Cardiol. 2020 May 26;75(20):2525-34.
https://www.sciencedirect.com/science/article/pii/S0735109720347458?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/32439001?tool=bestpractice.com
A 2020 cohort study showed that 10-year risk of all-cause dementia increases with diabetes, low education, and smoking, along with certain genes (apolipoprotein E and genome-wide association studies risk alleles), and, importantly, that healthy cardiovascular lifestyle attenuates genetic susceptibility for dementia.[51]Juul Rasmussen I, Rasmussen KL, Nordestgaard BG, et al. Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention. Eur Heart J. 2020 Nov 1;41(41):4024-33.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672536
http://www.ncbi.nlm.nih.gov/pubmed/33022702?tool=bestpractice.com
More recent studies have confirmed this interplay between cardiometabolic diseases, genetics and dementia risk. This ongoing research will enable high-risk individuals to be identified earlier in life, so that intervention can be targeted to prevent dementia later on.[52]Dove A, Guo J, Marseglia A, et al. Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry. Eur Heart J. 2023 Feb 14;44(7):573-82.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925275
http://www.ncbi.nlm.nih.gov/pubmed/36577740?tool=bestpractice.com
[53]Juul Rasmussen I, Frikke-Schmidt R. Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia. Eur Heart J. 2023 Jul 21;44(28):2526-43.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481783
http://www.ncbi.nlm.nih.gov/pubmed/37224508?tool=bestpractice.com
Multimorbidity (2 or more chronic diseases) is associated with an increased risk of dementia, particularly if onset is in midlife as opposed to later life, which makes prevention of multimorbidity in people with a first chronic disease increasingly important.[54]Ben Hassen C, Fayosse A, Landré B, et al. Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study. BMJ. 2022 Feb 2;376:e068005.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086721
http://www.ncbi.nlm.nih.gov/pubmed/35110302?tool=bestpractice.com
There is some evidence to suggest that regular physical activity is associated with a lower incidence of vascular dementia. Although the association is relatively weak, this is still important from a population health perspective.[55]Gallaway PJ, Miyake H, Buchowski MS, et al. Physical activity: a viable way to reduce the risks of mild cognitive impairment, Alzheimer's disease, and vascular dementia in older adults. Brain Sci. 2017 Feb 20;7(2):22.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332965
http://www.ncbi.nlm.nih.gov/pubmed/28230730?tool=bestpractice.com
[56]Hansson O, Svensson M, Gustavsson AM, et al. Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease. Alzheimers Res Ther. 2019 Oct 20;11(1):87.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802179
http://www.ncbi.nlm.nih.gov/pubmed/31630687?tool=bestpractice.com
[57]Iso-Markku P, Aaltonen S, Kujala UM, et al. Physical activity and cognitive decline among older adults: a systematic review and meta-analysis. JAMA Netw Open. 2024 Feb 5;7(2):e2354285.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10835510
http://www.ncbi.nlm.nih.gov/pubmed/38300618?tool=bestpractice.com
Daily step count correlates with reduced incidence of dementia up to 9800 steps per day, beyond which the benefits are reversed, and performing the steps at higher intensity is also associated with reduced dementia risk.[58]Del Pozo Cruz B, Ahmadi M, Naismith SL, et al. Association of daily step count and intensity with incident dementia in 78 430 adults living in the UK. JAMA Neurol. 2022 Oct 1;79(10):1059-63.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449869
http://www.ncbi.nlm.nih.gov/pubmed/36066874?tool=bestpractice.com
There is some historical controversy about lipid-lowering therapy and whether it may be a risk factor for cognitive decline but overall benefits, in terms of cardiovascular disease prevention, certainly appear to outweigh any risk. Long-term study outcomes are still pending.[59]Gebhard C, Corpataux N, Gräni C, et al. Lipid-lowering therapy and the risk of dementia: lessons learned from two decades of controversy. Eur Heart J. 2023 Jun 1;44(21):1855-7.
https://academic.oup.com/eurheartj/article/44/21/1855/7075233
High HDL levels in initially-healthy over ages 75 years has been shown to be associated with higher risk of all-cause dementia.[60]Hussain SM, Robb C, Tonkin AM, et al. Association of plasma high-density lipoprotein cholesterol level with risk of incident dementia: a cohort study of healthy older adults. Lancet Reg Health West Pac. 2024 Feb;43:100963.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10920036
http://www.ncbi.nlm.nih.gov/pubmed/38456089?tool=bestpractice.com
For people with hearing loss, hearing aids delay or prevent the onset and progression of dementia.[61]Cantuaria ML, Pedersen ER, Waldorff FB, et al. Hearing loss, hearing aid use, and risk of dementia in older adults. JAMA Otolaryngol Head Neck Surg. 2024 Feb 1;150(2):157-64.
http://www.ncbi.nlm.nih.gov/pubmed/38175662?tool=bestpractice.com
One large randomized controlled trial showed that giving aspirin to people with diabetes and no previous history of cardiovascular disease did not reduce their risk of developing dementia over the 7.4 year follow-up period.[62]Parish S, Mafham M, Offer A, et al. Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial. Eur Heart J. 2022 Jun 1;43(21):2010-9.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9242621
http://www.ncbi.nlm.nih.gov/pubmed/35393614?tool=bestpractice.com